- Home
- SNAL vs MODD Comparison
SNAL vs MODD Comparison
Compare SNAL & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNAL | MODD |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.8M | 33.3M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SNAL | MODD |
|---|---|---|
| Price | $0.64 | $0.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.7K | ★ 1.6M |
| Earning Date | 03-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | 34.62 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $84,467,047.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $50.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 38.69 | N/A |
| 52 Week Low | $0.56 | $0.12 |
| 52 Week High | $2.15 | $1.29 |
Technical Indicators
Market Signals| Indicator | SNAL | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 31.21 |
| Support Level | $0.58 | $0.12 |
| Resistance Level | $0.71 | $0.54 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 28.31 | 48.47 |
Price Performance
Historical ComparisonAbout SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.